Connection
Drew Kern to Antiparkinson Agents
This is a "connection" page, showing publications Drew Kern has written about Antiparkinson Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.233 |
|
|
|
-
Chaudhuri KR, Bergmans B, Freire-Alvarez E, Hopes L, Kern DS, Kirsner RS, Lazzeri G, Mendes-Bastos P, Nishikawa N, Odin P, Poplawska-Domaszewicz K, Pahwa R, Ramot Y, Seppi K, Warnecke T, Wiggins R, Shah MB, Kukreja P, Fritz B, Onuk K, Isaacson SH. Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease. Mov Disord Clin Pract. 2026 Jul; 13(7):1601-1611.
Score: 0.233